Guarneri V, Giorgi CA, Cinieri S, Bengala C, et al. Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial. Eur J Cancer 2021;154:21-29.
PMID: 34225066